Arterys is a developer of a Software-as-a-Service analytics platform to transform medical imaging diagnostics for improving the lives of patients and clinicians.
Arterys's mission is to radically transform the world of medical imaging via high performance cloud computation for the benefit of both patients and clinicians by creating an automated and intelligent diagnostic platform.
Arterys was founded in Sep 2011 by Albert Hsiao, Fabien Beckers, John Axerio-Cilies & shreyas Vasanawala. The company is headquartered in San Francisco, California with additional offices in Alberta, Canada and France.
Arterys set out to tackle several issues around the space, including the enormous workloads radiologists face, the lack of accuracy with many of today's tools, and the need for increased consistency across practices.
Arterys was the first to receive FDA clearance for a cloud-based product with Artificial Intelligence, and currently has 5 FDA clearances, and is active in 28 countries. The company continues to focus solving some of radiology's most pressing needs. By making imaging diagnostics quantitative, intelligent and available, Arterys seeks to improve the lives of millions of patients.
Arterys is backed by Temasek, Varian, Benslie Investment Group, Fosun, Revelation Partners, Northwell Health Ventures, NewYork-Presbyterian, GE Ventures and others. The company raised $28M in Series C round on May 30, 2020. This brings Arterys' total funding to $71.7M to date.